Observational Real-world Evidence (RWE) Study to Assess Patient-reported Wellbeing Using Tildrakizumab in Live Setting - POSITIVE Study

NCT04823247 · clinicaltrials.gov ↗
COMPLETED
Status
782
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Almirall, S.A.